ArticleWiener klinische Wochenschrift2026
Register and biobank on influence of assisted reproduction on pregnancy, maternal and neonatal outcome : A prospective multicenter medical data register and biobank.
Article in Wiener klinische Wochenschrift, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathological semen parameters according to WHO and Austrian IVF funds criteria and their association with pregnancy outcomes in assisted reproduction.Wiener medizinische Wochenschrift (1946) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfertility affects 10-15% of couples worldwide. In Austria, the In Vitro Fertilization Fund supports assisted reproductive technology under specific conditions. While assisted reproductive technology is generally effective, its impact on pregnancy and neonatal outcomes remains under discussion.
methodsThe Register and Biobank on the Influence of Assisted Reproduction on Pregnancy, Maternal and Neonatal Outcomes is a prospective multicenter register and biobank. It includes five in vitro fertilization centers and two obstetric departments in Vienna and Lower Austria. Standardized clinical and laboratory data are collected via electronic case report forms and pseudonymized using a unique code linking fertility and obstetric data. Recruitment started in 2022, and biobanking (blood, urine, placenta, and umbilical cord samples) was added in 2025.
resultsBy early 2025, complete data were available for 366 patients. Male infertility was the most frequent indication (231 cases), followed by tubal factor infertility, polycystic ovary syndrome, and endometriosis. The register enables linking of assisted reproductive technology procedures with detailed pregnancy and neonatal outcomes such as Apgar scores, delivery mode, and Neonatal Intensive Care Unit transfers.
conclusionThis register offers a unique real-world dataset connecting assisted reproductive technology treatment with maternal and neonatal outcomes. Continued recruitment will support hypothesis-driven research and improve assisted reproductive technology practices. It underlines the importance of high-quality, longitudinal data to understand potential assisted reproductive technology-related risks and guide future care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.